NCT06144762Recruiting
Precision Imaging for Early Detection and Targeted Treatment Monitoring in Pancreatic Cancer
Source: ClinicalTrials.gov · Last updated 12 Feb 2025 · Not updated for over 12 months - ask the site whether it is still open
Brief summary (registry, in English)
Specifically, in this project, the objective will be developped a model to capture imaging-based tumor heterogeneity with multiscale radiomics approach by obtaining the mirror tumor image at in vivo MRI, ex vivo MRI at histology. This imaging model giving a perfect virtual histology tumor representation will be secondary implemented on routine in vivo clinical MRI for early cancer detection and treatment monitoring. Successful completion of this proposal will lead to a comprehensive non invasive characterisation of pancreatic cancer and will be a game changer in patient management.
- Status (registry)
- Recruiting
- Study type
- Interventional
- Enrollment
- 150 (estimated)
- First submitted
- 13 Nov 2023
- Start date
- 19 Dec 2023
- Primary completion date
- Oct 2029
- Lead sponsor
- Institut du Cancer de Montpellier - Val d'Aurelle
- Diseases
- Pancreatic cancer, Ovarian cancer
- NCT number
- NCT06144762
What you commit to
- Study type: Interventional
- Planned participants: 150
- From 19 Dec 2023 to the primary completion date, Oct 2029
- 1 site in 1 country
- Visits and tests: ask the trial team, the registry does not list them
Built from the registry fields of ClinicalTrials.gov. It describes the study, not your situation.
Who cannot take part
Copied verbatim from ClinicalTrials.gov and grouped by topic. Only the trial team decides who can take part.
Prior treatment
- Patient who will not have surgery
Other
- presence of metastases,
- Pregnant or breastfeeding women
- Mental or psychological state, physical or legal incapacity preventing participation in the project.
Who the study is looking for
- Patient aged \>18 2.
- Pathologically proven pancreatic cancer which can beneficiate of upfront surgery or delayed surgery followed by neoadjuvant chemotherapy.
- Negative pregnancy test for women of childbearing potential
- Patients affiliated to a social protection system
- Written informed consent signed before project onset.
Age in the registry: 18 years to - · Sex: All · Does not accept healthy volunteers
Sites (1)
Sites in registry order. Pick your city on the disease page to sort them by distance.
| Site | City | Country | Site status |
|---|---|---|---|
| NOUGARET Stephanie Coordinator of this site? Confirm its status | Montpellier | France | Recruiting |
This page is information, not medical advice. Discuss any trial with your doctor.